Baxter International (BAX) has a debt-to-equity ratio of 1.56, above the Healthcare sector average of 0.28.
Get informed when a big investor buys or sells
+ Follow1.56
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
The latest debt-to-equity ratio for BAX is 1.56. That is above the Healthcare sector average of 0.28. Investors often review this figure alongside Baxter International's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, BAX currently prints 1.56 for debt-to-equity ratio, while the sector average sits near 0.28. That is roughly 463.3% above the sector mean. Large gaps often invite a closer look at Baxter International's growth, margins, and balance sheet.
A debt-to-equity ratio of 1.56 for Baxter International is not 'good' or 'bad' on its own. Compare it with the peer average (0.28) and with BAX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting BAX's debt-to-equity ratio (1.56), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Baxter International's debt-to-equity ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.